Loading...
Loading...
Browse all stories on DeepNewz
VisitWill Siemens Healthineers complete the acquisition of Novartis' Molecular Imaging Business by December 31, 2024?
Yes • 50%
No • 50%
Official press releases from Siemens Healthineers or Novartis, or major financial news outlets such as Bloomberg or Reuters
Siemens Healthineers to Acquire Novartis' Molecular Imaging Business in $224 Million Deal
Aug 26, 2024, 12:36 PM
Siemens Healthineers has agreed to acquire a part of Novartis' business specializing in radioactive chemicals used for cancer scans. The $224 million deal involves the molecular imaging business for Fluorine-18 positron emission tomography (PET) scans. This acquisition is expected to further boost Siemens Healthineers' healthcare operations. Novartis confirmed receiving a binding offer from Siemens Healthineers for this acquisition.
View original story
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
Completed by Q3 2025 • 25%
Completed by Q1 2025 • 25%
Completed by Q4 2025 • 25%
Completed by Q2 2025 • 25%
No significant increase • 25%
Increase by less than 2% • 25%
Increase by more than 5% • 25%
Increase by 2-5% • 25%